MHLW Bulletin Notifies of Revised Package Inserts Warning Concurrent Use of ARBs, ACE Inhibitors

The Ministry of Health, Labor and Welfare (MHLW) notified healthcare professionals in its pharmaceutical safety information bulletin on July 29 that package inserts of angiotensin receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors were revised to warn of their concurrent...read more